For said purpose “CIA International” (Russia) acquired substantial blocks of shares from three Russian pharmaceutical companies: “Biochimic”, “Syntez” and “Biosyntez”. The total amount of deal was USD27 million. About USD10 million will be invested this year in the new equipment for said pharma companies.